Phase I trial of the oral farnesyl protein transferase inhibitor lonafarnib (SCH66336): A Pediatric Brain Tumor Consortium (PBTC) study
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: M. W. Kieran, R. Packer, J. Boyett, M. Sugrue, L. Kun
Institution: Dana-Farber Cancer Institute
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2415453317
